Breaking News

The top earning health tech CEOs

August 19, 2025
avatar-mario-a
Health Tech Correspondent

Good morning health tech readers!

I'm back from vacation. It seems things were busy! What did I miss?

Reach me: mario.aguilar@statnews.com

business

Hims, Doximity CEOs top digital health earners

CEOs of  high-profile health tech companies are starting to pull in large pay checks on par with those of executives at big pharma companies, according to an analysis of 2025 proxy filings by STAT's Bob Herman and Emory Parker. Rather than rely on summary earnings, STAT's methodology leans on actual realized gains, which includes money from exercising vested stock. The analysis includes only public companies.

Andrew Dudum of telehealth company Hims and Hers Health came in fourteenth on the list with $51 million in earnings last year. Other notable health tech CEO payouts include include Doximity's Jeffrey Tangney and Dexcom's Kevin Sayer who each earned $18 million. The list also features leaders from mainstay medical device makers like Boston Scientific, Abbott, Stryker, Medtronic, Redmed, and more. Topping the list was BioNTech's Uğur Şahin, who pulled in $300 million. 

Read the full rundown here


Medical devices

A brain implant to translate inner monologue

Brain implant companies like Neuralank have raised hundreds of millions of dollars to give people with paralysis the ability to speak through a computer. A new study shows progress on a related but distinct problem: translating inner speech, or a person's inner monologue as they think about what to say.

As STAT's Rose Broderick reports, unlike "attempted speech," inner speech doesn't activate the muscles involved in talking, so figuring out how to decode it could have advantages for people with movement disorders such as amyotrophic lateral sclerosis. In a proof-of-concept study, four participants a computer semi-reliably decoded inner speech in real time, achieving up to 74% accuracy, from a 125,000-word vocabulary. 

Read more here


Did your company fulfill the White House health tech pledge? CMS will be the judge.

The Trump administration's effort to push health technology forward by securing voluntary commitments from companies has created an incentive to move quickly, as the plan's architects at the Centers for Medicare and Medicaid Services intended. But there are also unintended side effects of creating a race to be first to show progress: Companies are touting that they've signed the pledge and that they've already achieved its goals, even before CMS signs off.

Last week, Health Bank One put out a press release claiming to be the "first app to achieve CMS's vision for healthcare" with its patient health records app. Reached for comment on whether the company indeed meets the agency's criteria for an interoperable, modern patient health record app, a senior HHS official told my colleague Brittany Trang that "companies should be careful not to mislead on the effort. CMS will judge who has met the criteria." (Read more about Health Bank One and similar apps in last Thursday's newsletter.) The agency also clarified a couple more points regarding the pledge:

  • CMS will be posting additional names to the lists of companies agreeing to the pledge over the next weeks.
  • In the fine print for the pledge, CMS referred to "less mature" criteria that early pledge signees will help CMS develop. The agency clarified that it's an acknowledgement that some of its ambitious and visionary goals are still evolving, and that working groups will work on defining methods of achieving those goals.
  • For the AI assistant pledge specifically, the agency said that signing the agreement doesn't require each company to make an identical app. Those signees can do anything from "developing new tools, to enabling others through infrastructure or services, to aligning existing products with the principles outlined. That will be a business decision for each company based on what makes sense to them and their users."


Health tech news roundup

  • A redesigned version of the Apple Watch's blood oxygen feature is now available for newer models following a software update that allows users to view the data on their phones. Apple has been unable to sell devices that measure blood oxygen in the United States since 2023, when the International Trade Commission banned imports after a court found the feature violated patents of medical device maker Masimo
  • Eight Sleep, maker of a device that attempts to improve sleep by adjusting mattress temperature and playing soothing sounds, raised $100 million from HSG, Valor Equity Partners, Atreides, Founders Fund, and Y Combinator. The company plans to expand its medical applications beginning with menopausal sleep and sleep apnea, and it will seek Food and Drug Administration approval for some applications.
  • Atropos Health, developer of a real world data platform, announced a new deal with Novartis to develop AI-models for identifying people with paroxysmal nocturnal hemoglobinuria, a rare blood disorder.
  • Citizen Health, developer of tech to help people with rare diseases, announced $30 million in Series A funding led by 8VC.
  • Ambience Healthcare, developer of AI clinical documentation and billing tech, announced Chart Chat, an "'in-EHR' AI assistant for clinicians" that is "powered by OpenAI." Ambience recently announced a $243 million fundraise.
  • Ready for this? OpenEvidence announced that its AI-powered search engine for medical literature scored a perfect 100% on the U.S. medical licensing exam. Great. Reminder that illustrating the ability to "pass" these kinds of exams doesn't really tell us much about a product's value to health care.

More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

  • Bill Gates meets Willy Wonka: How Epic's 82-year-old billionaire CEO, Judy Faulkner, built her software factory, CNBC
  • Character.AI gave up on AGI. Now it's selling stories, Wired
  • He sold his likeness. Now his avatar is shilling supplements on TikTok. New York Times
  • Why direct-to-consumer sales are unlikely to significantly lower drug costs, STAT

Thanks for reading! More next time - Mario

Mario Aguilar covers how technology is transforming health care. He is based in New York.


Enjoying STAT Health Tech? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments